Kliiniset tutkimukset Nct sivu
Clinical Trial Results:
A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple Sclerosis Who Have Completed Trial 25643 (CLARITY).
| Summary | |
EudraCT number | 2007-000381-20 |
Trial protocol | FI FR GB CZ BE EE AT PT NL DE DK IT GR LV LT BG |
Global completion date | 16 Feb 2012 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 24 Jun 2016 |
First version publication date | 24 Jun 2016 |
Other versions | |
Summary report(s) | 2007-000381-20_CT.gov results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.